The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.
Clinical trial NCT04408937 · COMPLETED
Trial details
- NCT number
- NCT04408937
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-29
- Primary completion
- 2020-11-04
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.